Congress trades

Insmed Incorporated (INSM)

NASDAQ · Healthcare · 10 congress trades · last filed 2 months ago

10
Congress disclosures shown
35d
Median delay on the congress disclosures
of the 45 day limit
2/8
Purchases and sales in the disclosures shown

About Insmed Incorporated

from the company's filings and listing
Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
Chief executive
William H. Lewis
Employees
1,664
Listed since
Jun 1, 2000
Market value
$27.9B
Price to earnings
-
Earnings per share
-$4.03
Dividend yield
-

www.insmed.com

Earnings

6 reported quarters · next on Oct 29, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2026reported Aug 6, 2026-$0.06-$0.67$425.5M$395.5MEPS beatRevenue beat
Q1 FY2026reported May 7, 2026-$0.76-$0.96$306.0M$300.8MEPS beatRevenue beat
Q4 FY2025reported Feb 19, 2026-$1.54-$1.07$263.8M$231.2MEPS missRevenue beat
Q3 FY2025reported Oct 30, 2025-$1.75-$1.33$142.3M$115.4MEPS missRevenue beat
Q2 FY2025reported Aug 7, 2025-$1.70-$1.30$107.4M$104.1MEPS missRevenue beat
Q1 FY2025reported May 8, 2025-$1.42-$1.34$92.8M$91.5MEPS missRevenue in line

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for 2025 · proxy filed Apr 1, 2026
ExecutiveSalaryStock awardsOtherTotal
William H. LewisCEO$855K$3.0M$10.6M$14.5M
Martina Flammer, M.D.Chief Medical Officer$634K$875K$3.2M$4.7M
Roger AdsettChief Operating Officer$623K$875K$3.2M$4.7M
Sara BonsteinChief Financial Officer$583K$875K$3.2M$4.6M
Michael A. SmithChief Legal Officer$595K$750K$2.8M$4.1M

The summary compensation table from the 2025 proxy statement, current executives only. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesChangeOf company
FMR LLC$1.7B16,143,583+22.7%7.43%
Blackrock, Inc.$1.7B15,807,984-5.2%7.27%
Vanguard Portfolio Management LLC$1.1B10,407,962+0.3%4.79%
Jpmorgan Chase & Co$1.1B10,428,170-56.8%4.80%
Vanguard Capital Management LLC$1.0B9,790,865+1.5%4.50%
Baker Bros. Advisors LP$937.8M8,796,111+18.5%4.05%
Capital International Investors$878.3M8,238,124+47.2%3.79%
Darwin Global Management, Ltd.$673.6M6,431,163-61.7%2.96%
Ameriprise Financial Inc$658.9M6,179,571+102.1%2.84%
Orbis Allan Gray Ltd$647.9M6,076,487+224.5%2.80%
State Street Corp$645.3M6,052,174+9.0%2.78%
D. E. Shaw & Co., Inc.$626.7M5,877,959+4.5%2.70%

A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.

Know the moment the next INSM filing lands.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Congress trades in INSM

10 disclosures of 10 on record · median 35d of the 45 allowed
MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Josh GottheimerJointStockSale$1,001 - $15,000+40.2%S&P +5.1% · vs S&P 500 +35.1%Jun 10, 2026Jul 7, 202627d
Gilbert Ray Cisneros, Jr.Filed lateStockSale$1,001 - $15,000-18.0%S&P +13.9% · vs S&P 500 -31.9%Oct 3, 2025Nov 18, 202546d
Gilbert Ray Cisneros, Jr.StockSale$1,001 - $15,000-11.2%S&P +14.0% · vs S&P 500 -25.2%Sep 22, 2025Oct 10, 202518d
Gilbert Ray Cisneros, Jr.StockSale$1,001 - $15,000+17.6%S&P +19.7% · vs S&P 500 -2.1%Aug 8, 2025Sep 12, 202535d
Gilbert Ray Cisneros, Jr.StockSale$1,001 - $15,000+32.9%S&P +22.8% · vs S&P 500 +10.0%Jul 7, 2025Aug 14, 202538d
Josh GottheimerJointStockPurchase$1,001 - $15,000+26.8%S&P +26.5% · vs S&P 500 +0.3%Jun 16, 2025Jul 16, 202530d
Josh GottheimerJointStockSale$1,001 - $15,000+90.7%S&P +40.4% · vs S&P 500 +50.3%Apr 9, 2025May 14, 202535d
Josh GottheimerJointStockSale$1,001 - $15,000+89.4%S&P +39.7% · vs S&P 500 +49.8%Jun 21, 2024Jul 9, 202418d
Josh GottheimerJointStockSale$1,001 - $15,000+168.0%S&P +43.9% · vs S&P 500 +124.1%May 28, 2024Jun 8, 202411d
Josh GottheimerJointStockPurchase$1,001 - $15,000+578.6%S&P +93.6% · vs S&P 500 +485.0%Dec 6, 2022Jan 13, 202338d

Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.

Questions

Which members of Congress have traded INSM?

Josh Gottheimer, Gilbert Ray Cisneros, Jr. disclosed INSM transactions in the filings shown here.

How quickly are INSM trades disclosed?

Congressional disclosures took a median of 35 days, against the 45 the STOCK Act allows.

How to read a STOCK Act filing

WHAT THE FILING ACTUALLY SAYS

$A range, not an amount. Members disclose a band such as $1,001 to $15,000. The band is the filing, and we do not narrow it.
45Up to 45 days late, lawfully. The delay column counts calendar days from the transaction to its publication. Inside 45 days is within the law.
OPAn option names the underlying. A contract on a company is described using that company's name, so it can read like a share purchase. Those rows say otherwise.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Sep 10, 2026.

Related companies

traded by the same members

See every company we track